PharmaCyte Biotech Income Statement (2010-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jul2021	Oct2021	Jan2022	Apr2022	Jul2022	Oct2022	Jan2023	Apr2023	Jul2023	Oct2023	Jan2024	Apr2024	Jul2024	Oct2024	Jan2025	Apr2025	Jul2025	Oct2025	Jan2026	Apr2026
Shares Outstanding (Entity) (Quarter)	1.61M	20.72M	20.72M	15.52M	21.60M	21.60M	21.60M	21.60M	12.60M	8.77M	8.61M	9.58M	7.87M	7.64M	6.96M	7.33M	6.80M	6.80M	9.26M	8.38M
Revenue & cost
Revenue (Quarter)
Gross Profit (Quarter)
Operating items
Research & Development (Quarter)	0.14M	0.14M	0.16M	0.25M	0.16M	0.18M	0.05M	0.09M	0.10M	0.08M	0.13M	0.09M	0.10M	0.10M	0.12M	0.13M	0.10M	0.14M	0.09M	0.06M
Wages, Salaries and Other (Quarter)	0.27M	0.28M	0.27M	0.74M	0.90M	1.45M	0.25M	0.23M	0.33M	0.52M	0.62M	0.44M	0.51M	0.47M	0.23M
Selling, General & Administrative (Quarter)	0.36M	0.26M	0.22M	0.25M	0.24M	0.18M	0.36M	0.33M	1.36M	0.27M	0.25M	4.23M	1.17M	1.01M	0.84M	0.92M	0.75M	1.23M	2.02M	0.90M
Other Operating Expenses (Quarter)	0.52M	0.61M	0.48M	1.00M	1.28M	1.96M	1.15M	0.49M	0.62M	1.05M	1.49M	-1.16M								1.55M
Operating Expenses (Quarter)	1.02M	1.00M	0.86M	1.51M	1.68M	2.32M	1.55M	0.90M	2.08M	1.41M	1.87M	3.17M	1.27M	1.11M	0.96M	1.04M	0.85M	1.38M	2.12M	2.51M
Operating Income (Quarter)	-1.02M	-1.00M	-0.86M	-1.51M	-1.68M	-2.32M	-1.55M	-0.90M	-2.08M	-1.41M	-1.87M	-3.17M	-1.27M	-1.11M	-0.96M	-1.04M	-0.85M	-1.38M	-2.12M	-2.51M
EBIT (Quarter)	-1.02M	-1.00M	-0.86M	-1.51M	-1.68M	-2.32M	-1.55M	-0.90M	-2.08M	-1.41M	-1.87M	-3.17M	-1.27M	-1.11M	-0.96M	-1.04M	-0.85M	-1.38M	-2.12M	-2.51M
Non-operating items
Non Operating Investment Income (Quarter)															0.07M	-0.01M	-0.10M	-0.06M	-0.13M	-0.12M
Interest & Investment Income (Quarter)		0.03M	0.05M	0.09M	0.14M	0.44M	0.64M	0.72M	0.88M	0.89M	0.88M	0.75M	0.55M	0.38M	0.26M	0.23M	0.22M	0.21M	0.23M	0.08M
Other Non Operating Income (Quarter)	-0.00M	0.03M	-630.00	-0.00M	-0.00M	-0.00M	0.15M	0.05M	-1.45M	4.08M	0.01M	0.71M	2.08M	1.83M	4.49M	2.05M	0.24M	-10.47M	1.90M	3.59M
Non Operating Income (Quarter)	-0.00M	0.03M	0.04M	0.08M	0.14M	0.44M	0.79M	0.78M	-1.11M	4.20M	1.25M	4.51M	24.69M	-0.36M	-2.09M	12.79M	-7.51M	-6.04M	2.86M	-1.88M
Net income details
EBT (Quarter)	-1.02M	-0.99M	-0.81M	-1.42M	-1.55M	-1.88M	-0.91M	-0.18M	-1.20M	-0.52M	-0.99M	-17.61M	-0.72M	-0.72M	-0.70M	-16.03M	-0.63M	-1.17M	-1.89M	-21.80M
Profit After Tax (Quarter)	-1.03M	-0.98M	-0.81M	-1.42M	-1.55M	-1.88M	-0.76M	-0.13M	-3.18M	2.79M	-0.62M	1.35M	23.42M	-1.47M	-3.05M	11.75M	-8.36M	-7.42M	0.75M	-4.39M
Income from Non-Controlling Interests (Quarter)										-2.26M	-5.62M			-2.96M	-3.05M
Income from Continuing Operations (Quarter)	-1.02M	-0.99M	-0.81M	-1.42M	-1.55M	-1.88M	-0.91M	-0.18M	-1.20M	-0.52M	-0.99M	-17.61M	-0.72M	-0.72M	-0.70M	-16.03M	-0.63M	-1.17M	-1.89M	-21.80M
Consolidated Net Income (Quarter)	-1.02M	-0.99M	-0.81M	-1.42M	-1.55M	-1.88M	-0.91M	-0.18M	-1.20M	-0.52M	-0.99M	-17.61M	-0.72M	-0.72M	-0.70M	-16.03M	-0.63M	-1.17M	-1.89M	-21.80M
Income towards Parent Company (Quarter)	-1.02M	-0.99M	-0.81M	-1.42M	-1.55M	-1.88M	-0.91M	-0.18M	-1.20M	-0.52M	-0.99M	-17.61M	-0.72M	-0.72M	-0.70M	-16.03M	-0.63M	-1.17M	-1.89M	-21.80M
Preferred Dividend Payments (Quarter)									3.27M	4.46M	4.22M	4.16M	2.15M	1.05M		19.29M		0.90M	2.20M	0.40M
Net Income towards Common Stockholders (Quarter)	-1.02M	-0.99M	-0.81M	-1.42M	-1.55M	-1.88M	-0.76M	-0.13M	-6.78M	-2.26M	-5.62M	-2.54M	20.59M	-2.96M	-3.05M	8.78M	-8.36M	-8.42M	-1.56M	-4.87M
Additional items
EPS (Basic) (Quarter)	-0.64	-0.06	-0.04	-0.09	-0.07	-0.09	-0.04	-0.01	-0.54	-0.26	-0.65	-0.27	2.62	-0.39	-0.44	1.20	-1.23	-1.24	-0.17	-0.58
EPS (Diluted) (Quarter)	-0.64	-0.06	-0.04	-0.09	-0.07	-0.09	-0.04	-0.01	-0.54	-0.26	-0.65	-0.27	2.62	-0.39	-0.44	1.20	-1.23	-1.24	-0.17	-0.58
Shares Outstanding (Quarter)	1.59M	17.36M	21.67M	15.52M	20.83M	20.59M	19.00M	19.49M	12.60M	8.77M	8.61M	9.58M	7.87M	7.64M	6.96M	7.33M	6.80M	6.80M	9.26M	8.38M
Shares Outstanding (Diluted) (Quarter)	1.59M	17.36M	21.67M	15.52M	20.83M	20.59M	19.00M	19.49M	12.60M	8.77M	8.61M	9.58M	7.87M	7.64M	6.96M	7.33M	6.80M	6.80M	9.26M	8.38M
EBITDA (Quarter)	-1.02M	-1.00M	-0.86M	-1.51M	-1.68M	-2.32M	-1.55M	-0.90M	-2.08M	-1.41M	-1.87M	-3.17M	-1.27M	-1.11M	-0.96M	-1.04M	-0.85M	-1.38M	-2.12M	-2.51M
Interest Expenses (Quarter)	0.00M	0.01M	0.00M		0.00M	0.00M	-0.00M					15.19M				15.22M				19.37M

Research Tools

Datasets

Plans

Developers

PharmaCyte Biotech PMCB Income Statement (2010-2026)

Research Tools

Datasets

Plans

Developers

PharmaCyte Biotech PMCB Income Statement (2010-2026)

Create an account

Sign In

Reset Password